<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="Data frame containing the results of 16 trials comparing 8 treatments for
moderate-to-severe plaque psoriasis from an HTA report
(Woolacott et al. 2006)
, analysed in TSD2
(Dias et al. 2011)
. Outcomes are success/failure to achieve 50%,
75%, or 90% reduction in symptoms on the Psoriasis Area and Severity Index
(PASI) scale. Some studies report all three ordered outcomes, others only one
or two. The latter are coded as missing values (see details)."><title>HTA Plaque Psoriasis — hta_psoriasis • multinma</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/Source_Sans_Pro-0.4.9/font.css" rel="stylesheet"><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.11/clipboard.min.js" integrity="sha512-7O5pXpc0oCRrxk8RUfDYFgn0nO1t+jLuIOQdOMRp4APB7uZ4vSjspzp5y6YDtDs4VzUSTbWzBFZ/LKJhnyFOKw==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><link href="../extra.css" rel="stylesheet"><meta property="og:title" content="HTA Plaque Psoriasis — hta_psoriasis"><meta property="og:description" content="Data frame containing the results of 16 trials comparing 8 treatments for
moderate-to-severe plaque psoriasis from an HTA report
(Woolacott et al. 2006)
, analysed in TSD2
(Dias et al. 2011)
. Outcomes are success/failure to achieve 50%,
75%, or 90% reduction in symptoms on the Psoriasis Area and Severity Index
(PASI) scale. Some studies report all three ordered outcomes, others only one
or two. The latter are coded as missing values (see details)."><meta property="og:image" content="https://dmphillippo.github.io/multinma/logo.svg"><meta name="robots" content="noindex"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light" data-bs-theme="light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">multinma</a>

    <small class="nav-text text-danger me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="In-development version">0.7.0.9000</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/vignette_overview.html">Overview of Examples</a>
    <div class="dropdown-divider"></div>
    <h6 class="dropdown-header" data-toc-skip>Examples</h6>
    <a class="dropdown-item" href="../articles/example_atrial_fibrillation.html">Example: Atrial fibrillation</a>
    <a class="dropdown-item" href="../articles/example_bcg_vaccine.html">Example: BCG vaccine for tuberculosis</a>
    <a class="dropdown-item" href="../articles/example_blocker.html">Example: Beta blockers</a>
    <a class="dropdown-item" href="../articles/example_diabetes.html">Example: Diabetes</a>
    <a class="dropdown-item" href="../articles/example_dietary_fat.html">Example: Dietary fat</a>
    <a class="dropdown-item" href="../articles/example_hta_psoriasis.html">Example: Plaque psoriasis HTA report</a>
    <a class="dropdown-item" href="../articles/example_ndmm.html">Example: Newly diagnosed multiple myeloma</a>
    <a class="dropdown-item" href="../articles/example_parkinsons.html">Example: Parkinson's disease</a>
    <a class="dropdown-item" href="../articles/example_plaque_psoriasis.html">Example: Plaque psoriasis ML-NMR</a>
    <a class="dropdown-item" href="../articles/example_smoking.html">Example: Smoking cessation</a>
    <a class="dropdown-item" href="../articles/example_statins.html">Example: Statins for cholesterol lowering</a>
    <a class="dropdown-item" href="../articles/example_thrombolytics.html">Example: Thrombolytic treatments</a>
    <a class="dropdown-item" href="../articles/example_transfusion.html">Example: White blood cell transfusion</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/dmphillippo/multinma/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.svg" class="logo" alt=""><h1>HTA Plaque Psoriasis</h1>
      <small class="dont-index">Source: <a href="https://github.com/dmphillippo/multinma/blob/HEAD/R/data.R" class="external-link"><code>R/data.R</code></a></small>
      <div class="d-none name"><code>hta_psoriasis.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Data frame containing the results of 16 trials comparing 8 treatments for
moderate-to-severe plaque psoriasis from an HTA report
(Woolacott et al. 2006)
, analysed in TSD2
(Dias et al. 2011)
. Outcomes are success/failure to achieve 50%,
75%, or 90% reduction in symptoms on the Psoriasis Area and Severity Index
(PASI) scale. Some studies report all three ordered outcomes, others only one
or two. The latter are coded as missing values (see details).</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">hta_psoriasis</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>A data frame with 36 rows and 9 variables:</p><dl><dt>studyn</dt>
<dd><p>numeric study ID</p></dd>

<dt>studyc</dt>
<dd><p>study name</p></dd>

<dt>year</dt>
<dd><p>year of publication</p></dd>

<dt>trtn</dt>
<dd><p>numeric treatment code</p></dd>

<dt>trtc</dt>
<dd><p>treatment name</p></dd>

<dt>sample_size</dt>
<dd><p>sample size in each arm</p></dd>

<dt>PASI50, PASI75, PASI90</dt>
<dd><p>ordered multinomial outcome counts (exclusive, see details)</p></dd>


</dl></div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>Outcome counts are "exclusive"; that is, for a study reporting all
outcomes, the counts represent the categories 50 &lt; PASI &lt; 75, 75 &lt; PASI &lt;
90, and 90 &lt; PASI &lt; 100, and are named by the lower end of the interval.
(As opposed to "inclusive" counts, which would represent the overlapping
categories PASI &gt; 50, PASI &gt; 70, and PASI &gt; 90.) The count for the fourth
category (the lowest), 0 &lt; PASI &lt; 50, is equal to <code>sample_size - PASI50 - PASI75 - PASI90</code>.</p>
<p>Missing values are used where studies only report a subset of the outcomes.
For a study reporting only two outcomes, say 50 and 75, the counts
represent 50 &lt; PASI &lt; 75 and 75 &lt; PASI &lt; 100. For a study reporting only
one outcome, say PASI 75, the count represents 75 &lt; PASI &lt; 100.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Dias S, Welton NJ, Sutton AJ, Ades AE (2011).
“NICE DSU Technical Support Document 2: A generalised linear modelling framework for pair-wise and network meta-analysis of randomised controlled trials.”
National Institute for Health and Care Excellence.
<a href="https://www.sheffield.ac.uk/nice-dsu" class="external-link">https://www.sheffield.ac.uk/nice-dsu</a>.<br><br> Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Bravo Vergel Y, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R (2006).
“Etanercept and efalizumab for the treatment of psoriasis: a systematic review.”
<em>Health Technology Assessment</em>, <b>10</b>(46).
<a href="https://doi.org/10.3310/hta10460" class="external-link">doi:10.3310/hta10460</a>
.</p>
    </div>

  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by David M. Phillippo.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.9.</p>
</div>

    </footer></div>

  

  <script data-goatcounter="https://multinma.goatcounter.com/count" async src="//gc.zgo.at/count.js"></script></body></html>

